<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01835795</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE 06251612.7.0000.0068</org_study_id>
    <nct_id>NCT01835795</nct_id>
  </id_info>
  <brief_title>Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain</brief_title>
  <official_title>Prospective, Comparative, Randomized Study of the Effectiveness of Shock Wave Treatment in Myofascial Pain Syndrome in Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of treatment of radial shockwave in
      myofascial pain syndrome in the lumbar region compared to placebo through questionnaires and
      imaging exams.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Extracorporeal shockwave treatment has been used widely for musculoskeletal
      conditions, however no randomized controlled trial are available about its use for chronic
      low back pain with myofascial pain syndrome (MPS).

      HYPOTHESIS: Radial extracorporeal shockwave treatment (rESWT) improves pain intensity and
      functional disability compared with placebo in patients with chronic low back pain due to
      MPS.

      STUDY DESIGN: Randomized controlled clinical trial METHODS: A prospective, randomized,
      double-blind, placebo-controlled study will be carried out on 40 patients who has moderate to
      severe pain (VAS &gt; 4) for more than 6 months, despite 6 weeks of conservative treatment with
      antidepressants associated with rehabilitation. Six interventions of rESWT (3-4 bar; 1000
      impulses per trigger point (TP) or 2500 impulses per muscle) will be compared with placebo.
      The outcome measures were pain visual analogue scale (VAS), Oswestry Disability Index,
      Short-form McGill Pain Questionnaire, Roland Morris Disability Questionnaire and the
      temperature of the treated area will be evaluated with Thermography. The assessments will be
      apply before treatment, after conservative treatment, 6 and 12 weeks after rESWT.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 7, 2013</start_date>
  <completion_date type="Actual">January 18, 2019</completion_date>
  <primary_completion_date type="Actual">March 19, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of pain relief by visual analogue scale (VAS) of radial extracorporeal shock waves in myofascial pain syndrome in the lumbar and gluteal region compared to placebo</measure>
    <time_frame>12 weeks after the last session of shockwave</time_frame>
    <description>The outcome will be assessed by Visual Analogue Scale (VAS)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Myofascial Pain Syndromes</condition>
  <condition>Low Back Pain</condition>
  <condition>Lumbago</condition>
  <arm_group>
    <arm_group_label>Radial Extracorporeal Shock Wave</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Swiss DolorClast® CLASSIC applicator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Swiss DolorClast® CLASSIC placebo applicator</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Swiss DolorClast® CLASSIC applicator</intervention_name>
    <description>Radial Extracorporeal Shock Wave applicator use in 6 sessions with 1 week of interval, 1000 impulses per myofascial trigger point, 5 to 7 hertz frequency, 2 to 4 bar pressure</description>
    <arm_group_label>Radial Extracorporeal Shock Wave</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Swiss DolorClast® CLASSIC placebo applicator</intervention_name>
    <description>Placebo applicator, use in 6 sessions with 1 week of interval, 1000 impulses per myofascial trigger point, 5 to 7 hertz frequency, 2 to 4 bar pressure</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presenting clinical complaints of lumbar and / or gluteal pains for 3 months or more

          -  Display pain of moderate to severe intensity: visual analogue scale (VAS)&gt; 4

          -  Diagnosis of myofascial pain syndrome in the lumbar and / or gluteal

          -  Authorize in writing the term of free and informed consent to participate in the study

          -  Availability of frequent attendance at hospital

        Exclusion Criteria:

          -  Organic or psychological disorders that contraindication participation of patients in
             study

          -  Metabolic, infectious, oncological or rheumatologic disorders

          -  Fibromyalgia

          -  Labor dispute

          -  Indication for surgery in column

          -  Contraindications to therapy of shock waves:

               -  Coagulopathy and / or anticoagulant

               -  Pregnancy

               -  Acute infection in soft tissue or bone

               -  Systemic Infections

               -  Presence of ulcers at treatment sites

               -  Presence of larger vessels or nerves at treatment sites

               -  Polyneuropathies

               -  Malignancies

               -  Cardiac arrhythmias or use of pacemaker

               -  Epilepsy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ricardo Kobayashi</last_name>
    <role>Principal Investigator</role>
    <affiliation>IOT HCFMUSP - Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da USP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IOT HCFMUSP - Instituto de Ortopedia e Traumatologia do Hospital das Clínicas da Faculdade de Medicina da USP</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 14, 2013</study_first_submitted>
  <study_first_submitted_qc>April 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2013</study_first_posted>
  <last_update_submitted>April 27, 2019</last_update_submitted>
  <last_update_submitted_qc>April 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Ricardo Kobayashi</investigator_full_name>
    <investigator_title>Researcher and Collaborator of Pain Group</investigator_title>
  </responsible_party>
  <keyword>Myofascial Pain Syndromes</keyword>
  <keyword>Myofascial Trigger Point</keyword>
  <keyword>Low Back Pain</keyword>
  <keyword>Lumbago</keyword>
  <keyword>Shock Waves, High-Energy</keyword>
  <keyword>High-Energy Shock Waves</keyword>
  <keyword>Interdisciplinary Health Team</keyword>
  <keyword>Multidisciplinary Pain Centers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

